Tower Research Capital LLC (TRC) - MAXCYTE INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$9,373
-71.5%
3,004
-58.0%
0.00%
-100.0%
Q2 2023$32,850
+93757.1%
7,157
+0.7%
0.00%0.0%
Q1 2023$35
+118.8%
7,108
+139.8%
0.00%0.0%
Q4 2022$16
-100.0%
2,964
-85.7%
0.00%
-50.0%
Q3 2022$134,000
+458.3%
20,676
+305.2%
0.00%
+100.0%
Q2 2022$24,000
+166.7%
5,103
+260.9%
0.00%
Q1 2022$9,000
-72.7%
1,414
-57.1%
0.00%
-100.0%
Q4 2021$33,000
-67.0%
3,298
-59.9%
0.00%
-66.7%
Q3 2021$100,0008,2160.00%
Other shareholders
MAXCYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,885,000$5,881,2005.55%
Vitruvian Partners LLP 5,043,356$15,735,2714.46%
Stonepine Capital Management, LLC 3,761,640$11,736,3173.90%
Mudita Advisors LLP 1,390,858$4,339,4773.17%
RIVER GLOBAL INVESTORS LLP 1,473,254$4,588,3591.07%
Casdin Capital, LLC 1,890,000$5,896,8000.65%
Portolan Capital Management 2,143,666$6,688,2380.62%
Grandeur Peak Global Advisors, LLC 1,434,819$4,476,6350.34%
First Light Asset Management, LLC 1,073,110$3,348,1030.32%
Granahan Investment Management 1,975,847$6,164,6430.22%
View complete list of MAXCYTE INC shareholders